Author:
Hsu Kai-Cheng,Hung Hui-Chen,HuangFu Wei-Chun,Sung Tzu-Ying,Eight Lin Tony,Fang Ming-Yu,Chen I-Jung,Pathak Nikhil,Hsu John T.-A.,Yang Jinn-Moon
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Liu, Y., Zhang, J. & Xu, W. Recent progress in rational drug design of neuraminidase inhibitors. Curr. Med. Chem. 14, 2872–2891 (2007).
2. Chang, S. C., Cheng, Y. Y. & Shih, S. R. Avian influenza virus: the threat of a pandemic. Chang Gung Med. J. 29, 130–134 (2006).
3. Zhang, Z. et al. Spatio-temporal data comparisons for global highly pathogenic avian influenza (HPAI) H5N1 outbreaks. PLoS One 5, e15314 (2010).
4. Tanaka, T. et al. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. Can. Med. Assoc. J. 181, 55–58 (2009).
5. Russell, R. J. et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443, 45–49 (2006).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献